Pharmaceutical News | Industry News - SME News

Elder introduces three-female personal hygiene products in India

songbedna — Mon, 27 Feb 2012 11:08:01 +0000

MUMBAI: Elder Pharmaceuticals has unveiled three-female personal hygiene products in the country as part of the in-licensing agreement with US-based company Combe Inc.

The firm has unveiled the 'Vagisil' range of feminine personal hygiene products in India in partnership with the New York-based Combe Inc, which is an international brand in feminine care, said Elder Pharma in a statement.

Pharma sector faces trouble in finding skilled people for R&D

songbedna — Sat, 25 Feb 2012 10:07:03 +0000

MUMBAI: The pharmaceutical firms focus on Research and Development (R&D) to continue its presence in the international market with the commencement of the product patent era but have been finding it problematic to hire skilled people.

MSD India plans further collaborations for expansion of product presence

songbedna — Sat, 25 Feb 2012 07:18:13 +0000

NEW DELHI: MSD India, a drug company, has stated that it is eyeing for commercial collaborations, similar to the one it has with Sun Pharma, for the expansion of the product presence in the domestic market, said KG Ananthakrishnan, Managing Director of MSD India.

USFDA nod for Strides Arcolab's Brazilian plant

songbedna — Fri, 24 Feb 2012 10:43:56 +0000

NEW DELHI: Strides Arcolab has bagged the nod of the USFDA for its Brazilian plant that manufactures sterile dry powder antibiotic injectables.
A statement from Strides Arcolab, said, “The approval is also the first USFDA approval for an international facility of Strides.”

Panacea Biotec introduces polio vaccine 'Polprotec' in Nigeria

songbedna — Fri, 24 Feb 2012 10:05:04 +0000

ABUJA: Pharmaceutical company Panacea Biotec has unveiled a polio vaccine, Polprotec, in Nigeria with the aim to help control the spread of polio here.

With the aim to make the vaccine easily available, Panacea Biotec is collaborating with Emzor pharma which enjoys robust foothold across Nigeria. The nation has been witnessing the challenge of polio virus.

Pharma traders in Kashmir orangise 2-day strike against new drug policy

songbedna — Fri, 24 Feb 2012 08:32:00 +0000

SRINAGAR: The pharmaceuticals traders in Kashmir Valley have started two-day strike against the new drug policy today. This policy has been formulated by the state government. The two-day strike call has been given by the apex body of pharma dealers post a meeting here yesterday.

First vaccine to prevent fatal parasitic disease 'kala azar' enters clinical trials

prerna — Thu, 23 Feb 2012 12:17:39 +0000

HOUSTON: The first-ever vaccine to prevent world's second largest parasitic killer after malaria, kala azar or black fever, has been originated and the clinical trials to test the vaccine have been scheduled in India, the epicentre of the disease, along with the US.

Indian drug firms see growth potential in African anti-malarial drug market

prerna — Thu, 23 Feb 2012 06:44:35 +0000

MUMBAI: The Indian pharmaceutical firms are betting big on African markets and eyeing a healthy growth potential in the African anti-malarial drugs market.

On the same hopes, the strategy of Bliss GVS Pharma provides fruitful results to the company's revenue with marketing of its anti-malarial medicines through retail channels in African countries.

Amrita Centre for Nanosciences launches drug for neuro-endocrine tumours

prerna — Wed, 22 Feb 2012 12:33:22 +0000

KOCHI: The premier research and educational institution in the area of nano-biotechnology, the Amrita Centre for Nano Sciences and Molecular Medicine (ACNSMM), has announced the launch of a wonder drug to treat neuro-endocrine tumours.

The drug, Nanophotomedicine, has been developed at the Amrita Centre by a team chaired by Manzoor Koyakutty. Amrita Centre belongs to Mata Amritananda Mayi.

Short-supply cancer drug 'Lipodox' to be imported from India

songbedna — Wed, 22 Feb 2012 07:54:10 +0000

WASHINGTON: US health authorities has stated that they will be importing a drug to treat ovarian, bone marrow and AIDS-related skin cancer from India with the aim to ward off worrying shortage.

Aurobindo Pharma eyes USFDA audit on Unit VI by July

songbedna — Wed, 22 Feb 2012 04:59:02 +0000

HYDERABAD: Aurobindo Pharma Ltd will continue to witness revenue loss due to the ban of US Food and Drug Administration on the Unit VI for over six months.

The city-based firm was hoping that the inspectors from the US regulator to audit its unit between June-July this year, said Mr Ramprasad Reddy, Chairman, Aurobindo Pharma Ltd.

Ranbaxy unveils generic Atorvastatin in Australia

songbedna — Tue, 21 Feb 2012 11:34:12 +0000

GURGAON: Ranbaxy Laboratories, a drug company, has stated that its arm Ranbaxy Australia Pty Ltd (RAPL) has unveiled generic Atorvastatin tablets, which is used for lowering cholesterol, in the Australian market.

2-day Indo-German research scientists meet kicks off in Hyderabad today

prerna — Tue, 21 Feb 2012 09:44:23 +0000

HYDERABAD: The two-day Indo-German research scientists meet kicks off today at the University of Hyderabad to share the experience and expertise in the field of life sciences with the help of presentations, seminars and interviews.

CDSCO mulls to establish 5-central drugs testing laboratories for cosmetics industry

songbedna — Mon, 20 Feb 2012 10:00:42 +0000

NEW DELHI: The Central Drugs Standard Control Organisation (CDSCO) is planning to establish five-new laboratories for testing the quality of cosmetics as the industry in India is on the surge and the authorities have been resorting to steps to address the loopholes for ensuring the quality.

Indian Patent Office straining to clear huge backlog of 1 lakh pending patent applications by 2016

prerna — Mon, 20 Feb 2012 09:32:33 +0000

MUMBAI: The Indian Patent Office is putting steady efforts to clear the huge backlog of about one lack pending patent applications as earlier by 2016, in a view to protect the interest of the patent applicants.

In the same move, the patent office has already recruited 150 examiners to deal with the excess files and increased work pressure.

Pfizer scouts for partners in India in treating cancer patients

prerna — Sat, 18 Feb 2012 06:40:01 +0000

HYDERABAD: Global research-based pharmaceutical company, Pfizer, is looking for partnerships pharmaceutical majors in India in treating cancer patients. The company draws plans for the heavy investment into the oncology research.

Scottish Development International looks at closer ties with India to attract investors

songbedna — Thu, 16 Feb 2012 07:06:49 +0000

NEW DELHI: Scottish Development International (SDI), which is a joint venture between the Scottish Government, Scottish Enterprise and Highlands & Islands Enterprise, is eyeing to develop closer relations with India to lure the prospective investors from the life sciences sector for investing in Scotland.

Sanofi Pasteur partners with Emcure Pharmaceuticals for anti-rabies vaccine 'Verorab'

songbedna — Thu, 16 Feb 2012 06:57:51 +0000

MUMBAI: Sanofi Pasteur, a vaccines division of Sanofi, has announced the formalisation of a marketing and distribution pact with Pune's Emcure Pharmaceuticals for the anti-rabies vaccine -Verorab.

The product will be imported and supplied by Sanofi Pasteur India Private Ltd and then it will be marketed and distributed by Emcure via its subsidiary, Zuventus Healthcare, according to Sanofi.

Mumbai to host 11th IPC-USP Science & Standards Symposium during Feb 22 & 23

prerna — Wed, 15 Feb 2012 08:08:09 +0000

MUMBAI: The Indian Pharmacopoeia Commission-US Pharmacopeial Convention (USP) will organise the 11th IPC-USP Science & Standards Symposium here during February 22-23.

The conference will be focussed on the global quality standards for biologic medicines and supply chain management.

Health ministry to take more time to appoint head of DCGI office

imart2 — Wed, 15 Feb 2012 07:12:14 +0000

NEW DELHI: The Union Health Ministry has once again failed to name new candidate for the head of the Drug Controller General of India (DCGI) in the country. The office is running without permanent head as the short tenure of interim DCGI, Dr V G Somani expired on February 1, 2012.